We are live on ! Find out more
CC

Corton Capital Portfolio holdings

AUM $40.7M
1-Year Est. Return 52.32%
This Fund
S&P 500
This Quarter Est. Return
+19.06%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$31.4M
Cap. Flow
-$50.7M
Cap. Flow %
-29.09%
Top 10 Hldgs %
48.99%
Holding
691
New
222
Increased
56
Reduced
93
Closed
319

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$614K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$592K
3
AMAT icon
Applied Materials
AMAT
+$582K
4
SBGI icon
Sinclair Inc
SBGI
+$529K
5
PRAA icon
PRA Group
PRAA
+$525K

Top Sells

Rank Stock Value
1
IGMS
IGM Biosciences
IGMS
+$1.1M
2
ROOT icon
Root
ROOT
+$981K
3
CDNA icon
CareDx
CDNA
+$929K
4
TRDA icon
Entrada Therapeutics
TRDA
+$924K
5
SO icon
Southern Company
SO
+$883K

Sector Composition

Rank Sector Weight
1 Technology 55.81%
2 Healthcare 9.35%
3 Financials 7.03%
4 Industrials 6.34%
5 Consumer Discretionary 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADC icon
376
Agree Realty
ADC
$9.33B
– –
-3,748
Closed -$282K
ADMA icon
377
ADMA Biologics
ADMA
$1.94B
– –
-25,989
Closed -$520K
AGYS icon
378
Agilysys
AGYS
$2.97B
– –
-2,039
Closed -$222K
AKRO
379
DELISTED
Akero Therapeutics
AKRO
– –
-7,571
Closed -$217K
ALEC icon
380
Alector
ALEC
$171M
– –
-23,237
Closed -$108K
ALK icon
381
Alaska Air
ALK
$5.31B
– –
-9,206
Closed -$416K
AME icon
382
Ametek
AME
$55.6B
– –
-1,492
Closed -$256K
AMLX icon
383
Amylyx Pharmaceuticals
AMLX
$2.15B
– –
-13,104
Closed -$42.5K
GOLD
384
Gold.com Inc
GOLD
$1.19B
– –
-9,178
Closed -$405K
AMT icon
385
American Tower
AMT
$80B
– –
-969
Closed -$225K
ANAB icon
386
AnaptysBio
ANAB
$1.56B
– –
-7,684
Closed -$257K
AORT icon
387
Artivion
AORT
$1.31B
– –
-9,621
Closed -$256K
APD icon
388
Air Products & Chemicals
APD
$65.3B
– –
-1,388
Closed -$413K
APPF icon
389
AppFolio
APPF
$6.3B
– –
-864
Closed -$203K
APPN icon
390
Appian
APPN
$1.98B
– –
-13,634
Closed -$465K
ARKO icon
391
ARKO Corp
ARKO
$886M
– –
-47,694
Closed -$335K
ARVN icon
392
Arvinas
ARVN
$514M
– –
-11,691
Closed -$288K
ARWR icon
393
Arrowhead Research
ARWR
$12B
– –
-20,268
Closed -$393K
ASC icon
394
Ardmore Shipping
ASC
$705M
– –
-13,608
Closed -$246K
ASYS icon
395
Amtech Systems
ASYS
$268M
– –
-25,359
Closed -$147K
ATKR icon
396
Atkore
ATKR
$2.45B
– –
-6,721
Closed -$570K
ATLC icon
397
Atlanticus Holdings
ATLC
$1.59B
– –
-6,435
Closed -$226K
ATNI icon
398
ATN International
ATNI
$367M
– –
-8,194
Closed -$265K
ATXS
399
DELISTED
Astria Therapeutics
ATXS
– –
-20,492
Closed -$226K
AU icon
400
AngloGold Ashanti
AU
$39B
– –
-10,416
Closed -$277K
14 15
16
17 18

Similar funds

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
AM
Arkhouse Management New York $36.7M AUM
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
OC
ORIX Corp Tokyo, Japan $36.6M AUM 25.1% 1-Year Est. Return
HCM
HGI Capital Management New York $36.4M AUM 4.49% 1-Year Est. Return
PI
Pelion Inc Salt Lake City, Utah $36.3M AUM 3.33% 1-Year Est. Return

Corton Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Corton Capital held 691 positions worth $174M, down 15% from $206M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Corton Capital withdrew a net $50.7M in Q4 2024, closing 319 positions and reducing 93 holdings. Its most notable exit was IGM Biosciences, an estimated $1.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Corton Capital opened a new position in Progressive worth $585K.

  • Corton Capital's largest Q4 2024 buy was Progressive: 2,441 shares worth $585K.
  • Corton Capital added most to United Natural Foods in Q4 2024, an estimated $439K increase.
  • Corton Capital's biggest Q4 2024 reduction was Root, cutting an estimated $981K.
  • Corton Capital fully exited IGM Biosciences in Q4 2024, selling an estimated $1.1M.
  • Corton Capital's ten largest holdings make up 49% of its $174M portfolio in Q4 2024.
  • Corton Capital opened 222 new positions and closed 319 in Q4 2024.
  • Corton Capital's portfolio value fell 15% quarter-over-quarter to $174M.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.